Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Colorectal Neoplasms 2Breast Neoplasms 2Stress Disorders, Post-Traumatic 1Sleep Wake Disorders 1Prostatic Neoplasms 1Neoplasms 1Neoplasm, Residual 1Lymphoma, Follicular 1Leukemia, Hairy Cell 1Leukemia 1Fatigue 1Depression 1Colonic Neoplasms 1Cardiotoxicity 1Anxiety Disorders 1

Interventions

Bevacizumab 112Fluorouracil 98Oxaliplatin 96Leucovorin 96Irinotecan 86Capecitabine 73Cetuximab 64Panitumumab 42pembrolizumab 38regorafenib 28Nivolumab 23IFL protocol 22Folfox protocol 21trifluridine tipiracil drug combination 14Radiotherapy 13durvalumab 11Gemcitabine 10Celecoxib 9tremelimumab 7binimetinib 7aflibercept 7Drug Therapy 7Disulfides 7Cyclophosphamide 7Trifluridine 6Trastuzumab 6Sunitinib 6Immunoglobulin G 6Colonoscopy 6130-nm albumin-bound paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Colorectal Neoplasms × Exercise Test × Clear all
NCT00819208 2026-04-24

CHALLENGE

Canadian Cancer Trials Group

Phase NA Completed
889 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Colonic Neoplasms, Depression, Fatigue, Sleep Wake Disorders, Colorectal Neoplasms

NCT06016725 2026-01-02

E-PROOF

Ohio State University Comprehensive Cancer Center

Phase NA Completed
75 enrolled 27 charts
GastrointestinalGenitourinary

Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡